Answers are grounded in this paper and cite their sources.
Subcutaneous extravasation of infused vesicant solutions is becoming a common problem in medical practice, and can result in severe and progressive tissue dysfunction, ranging from persistent tissue edema to tissue necrosis. Although Acyclovir is a known vesicant drug, responsible for venous and soft tissue irritation, they are a few reported cases of extravasation of Aciclovir. We report here the 5th case of Subcutaneous extravasation of intravenous (IV) acyclovir in a patient hospitalized for herpes zoster cruris, causing skin necrosis on day 4 of her hospitalization and leaving a residual scar. Early recognition of extravasation and prompt management are essential to prevent additional morbidity and optimize outcomes.
No takes yet. Share an insight, caveat, or question.
Couissi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: